Table 4.
Plans | CTV PT 1% (SD) |
ITV PT 100% (SD) |
CTV LN 1% (SD) |
ITV LN 100% (SD) |
|
---|---|---|---|---|---|
1. Unadapted 66 Gy | 97.2 (0.9) | 20.9 (12.8) | 98.5 (0.4) | 42.0 (13.2) | |
2. Adapted 66 Gy | 97.3 (0.9) | 22.5 (13.5) | 98.5 (0.5) | 42.0 (13.2) | |
p-values 1. versus 2. | <0.01 | <0.005 | > 0.05 | > 0.05 | |
Plan A | |||||
3. not exceeding any normal tissue tolerance | 98.0 (1.3) | 44.6 (28.3) | 98.5 (0.5) | 43.2 (15.0) | |
p-values 2. versus 3. | <0.01 | < 0.01 | > 0.05 | > 0.05 | |
Plan B | |||||
4. not exceeding any normal tissue tolerance | 98.2 (1.3) | 45.9 (28.0) | 98.6 (0.4) | 45.9 (14.3) | |
p-values 2. versus 4. | < 0.01 | < 0.01 | > 0.05 | <0.01 |
CTV: clinical target volume; ITV: internal target volume; LN: lymph nodes; PT: primary tumor; SD: standard deviation; TCP: tumor control probability.